Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer
Molecular & Cellular Proteomics · 2024-10 · 23 (10) · 100834
DOI: 10.1016/j.mcpro.2024.100834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2024-10. Verfasst von Patricia Mondelo-Macía und 9 weiteren Autor:innen. Beteiligte Einrichtung: Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), Santiago de Compostela, Spain; U…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proteomics, Immunotherapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), Santiago de Compostela, Spain; Universidade de Santiago de Compostela (USC), Santiago de Compostela, S…
- Department of Medical Oncology, Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), Santiago de Compostela, Spain; Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDI…
- Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain; Galician Precision Oncology Research Group (ONCOGAL), Medicine and Dentistry School, Universidade de Santiago de Compostela (USC), Santiago de…
- Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), Santiago de Compostela, Spain.
- Proteomic Unit, Instituto de Investigaciones Sanitarias-IDIS, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
- Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), Santiago de Compostela, Spain; Galician Precision Oncology Research Group (ONCOGAL), Medicine and Dent…
Zitieren
APA
Mondelo-Macía, P., García-González, J., León-Mateos, L., Abalo, A., Bravo, S., Chantada Vazquez, M. D. P., Muinelo-Romay, L., López-López, R., Díaz-Peña, R., & Dávila-Ibáñez, A. B. (2024). Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer. Molecular & Cellular Proteomics, 23(10), 100834. https://doi.org/10.1016/j.mcpro.2024.100834
Vancouver
Mondelo-Macía P, García-González J, León-Mateos L, Abalo A, Bravo S, Chantada Vazquez MDP, et al. Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer. Molecular & Cellular Proteomics. 2024;23(10):100834. doi:10.1016/j.mcpro.2024.100834
BibTeX
@article{MondeloMaca2024,
author = {Mondelo-Macía, Patricia and García-González, Jorge and León-Mateos, Luis and Abalo, Alicia and Bravo, Susana and Chantada Vazquez, María Del Pilar and Muinelo-Romay, Laura and López-López, Rafael and Díaz-Peña, Roberto and Dávila-Ibáñez, Ana B},
title = {Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer},
journal = {Molecular & Cellular Proteomics},
year = {2024},
volume = {23},
number = {10},
pages = {100834},
doi = {10.1016/j.mcpro.2024.100834}
}
EUVIMED